# Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension

> **NCT05277870** · NA · UNKNOWN · sponsor: **University of Washington** · enrollment: 150 (estimated)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **DEVICE:** Nanodropper adaptor
- **DEVICE:** control

## Key facts

- **NCT ID:** NCT05277870
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-28
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05277870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05277870, "Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05277870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*